NYSE · PHG
Healthcare · Medical - Devices
$26.72
Down-$0.12 (-0.43%)
Updated Aug 31, 2026, 3:35 PM
SID Score
5.0/10
Composite research score
Smart Money
54/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PHG closed at $26.72 after 20 trading sessions, up 1.87% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $26.90 | $26.94 | $26.66 | $26.72 | 531.71K |
| Aug 27, 2026 | $26.72 | $27.08 | $26.61 | $26.92 | 548.56K |
| Aug 26, 2026 | $27.32 | $27.32 | $26.86 | $26.99 | 751.85K |
| Aug 25, 2026 | $27.33 | $27.455 | $27.23 | $27.43 | 469.02K |
| Aug 24, 2026 | $27.52 | $27.69 | $27.44 | $27.52 | 566.57K |
| Aug 21, 2026 | $27.31 | $27.62 | $27.16 | $27.42 | 753.89K |
| Aug 20, 2026 | $27.53 | $27.765 | $27.50 | $27.50 | 586.71K |
| Aug 19, 2026 | $27.25 | $27.655 | $27.23 | $27.62 | 827.45K |
| Aug 18, 2026 | $27.10 | $27.355 | $27.045 | $27.10 | 702.68K |
| Aug 17, 2026 | $27.16 | $27.26 | $26.76 | $26.82 | 866.22K |
| Aug 14, 2026 | $27.62 | $27.632 | $27.27 | $27.29 | 470.95K |
| Aug 13, 2026 | $27.295 | $27.39 | $27.05 | $27.38 | 836.52K |
| Aug 12, 2026 | $26.72 | $26.87 | $26.53 | $26.80 | 700.7K |
| Aug 11, 2026 | $27.23 | $27.39 | $27.03 | $27.05 | 1.15M |
| Aug 10, 2026 | $26.70 | $27.005 | $26.70 | $26.94 | 1M |
| Aug 7, 2026 | $26.66 | $26.86 | $26.48 | $26.73 | 729.42K |
| Aug 6, 2026 | $26.55 | $26.64 | $26.2323 | $26.33 | 891.08K |
| Aug 5, 2026 | $26.47 | $26.60 | $26.33 | $26.59 | 952.25K |
| Aug 4, 2026 | $26.39 | $26.535 | $26.26 | $26.47 | 972.28K |
| Aug 3, 2026 | $26.43 | $26.775 | $26.025 | $26.23 | 1.08M |
The latest Smart Investors Daily articles mentioning PHG.
PHG research
Company profile and research snapshot.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 12, 2026 | DAY BY DAY | Buy | — |
| Jul 8, 2026 | ROTHSCHILD & CO REDBURN | Neutral | — |
| Jul 6, 2026 | JEFFERIES | Hold | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 1, 2026 | ING FM | Hold | — |
No generated briefing is available yet.
Benzinga · Aug 26, 2026
Award from ARPA-H to expand access to AI-enabled robotic stroke care, supporting the program's goal of expanding access to specialized interventionsPhilips will collaborate with Johns Hopkins University and Boston
Benzinga · Aug 11, 2026
Exor and Philips update their long-term agreement, allowing Exor to boost its shareholding in Philips up to 22%. Read the details.
Benzinga · Aug 11, 2026
It provides Exor with the flexibility to increase its shareholding in Philips to up to 22% of the company’s issued ordinary share capital and voting rights, up from the previous 20% cap, with the possibility of
SeekingAlpha · Aug 4, 2026
Philips Q2 update: 4% comp sales growth, strong emerging markets, â¬258m H1 savings and better margins.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PHG.
